NOW Magnesium Citrate Softgel Mislabeling Investigation
Case Overview
Attorneys are currently investigating whether the NOW Magnesium Citrate Softgels contain the specific amount and type of magnesium that is advertised on the product's label. The core concerns revolve around whether the softgels provide less magnesium than the stated 400 mg, or if they contain a different, unlisted source of magnesium that may be harder for the body to absorb.
The investigation is prompted by the fact that the label's stated blend of compounds does not appear to mathematically align with the advertised 400 mg of magnesium. Attorneys are examining whether the product's claims meet federal labeling requirements, which mandate that supplement labels cannot contain false or misleading information regarding the amount and type of minerals provided.
Who May Qualify
Individuals who purchased NOW Magnesium Citrate Softgels on or before May 31, 2024, in the United States.
Frequently Asked Questions
What is the investigation about?
Attorneys are looking into whether the NOW Magnesium Citrate Softgels actually contain the amount and type of magnesium that the product label claims. They are specifically questioning the accuracy of the label's stated 400 mg of magnesium.
Who can participate in this investigation?
People who bought NOW Magnesium Citrate Softgels and made their purchase on or before May 2024 may qualify to participate in the investigation.
Why is the label math concerning?
The concern is that the label's stated blend of compounds does not seem to add up to the advertised 400 mg of magnesium, especially when considering the actual percentage of magnesium in each compound listed.
Related Cases
Iraq War Lawsuit for Injuries Sustained in Iraq or Afghanistan
Ozempic & GLP-1 Drugs Vision Loss (NAION) Class Action